Tag: Biopharmaceuticals
DaHui hires private equity partner in corporate boost
DaHui Lawyers adds PE partner Jason Song to its Shanghai team
Han Kun advises 3SBio in landmark Pfizer licensing deal
3SBio inks major licensing deal with Pfizer for cancer drug SSGJ-707
Four law firms act on ImmuneOnco IPO, HK’s first since July
Four law firms have facilitated ImmuneOnco Biopharmaceuticals’ USD40.7 million IPO on the HKEX, breaking a 50-day hiatus in listings on the Hong Kong bourse












